Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1968 1
1969 1
1971 1
1972 2
1973 1
1974 2
1975 1
1977 1
1981 2
1983 1
1994 1
1997 1
1998 2
1999 1
2001 1
2002 2
2004 1
2007 3
2008 1
2009 2
2010 3
2011 1
2013 5
2014 5
2015 6
2016 9
2017 9
2018 10
2019 12
2020 14
2021 11
2022 11
2023 6
2024 7
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group. Stone JH, et al. N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905. N Engl J Med. 2010. PMID: 20647199 Free PMC article. Clinical Trial.
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC; Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group. Geetha D, et al. J Am Soc Nephrol. 2015 Apr;26(4):976-85. doi: 10.1681/ASN.2014010046. Epub 2014 Nov 7. J Am Soc Nephrol. 2015. PMID: 25381429 Free PMC article. Clinical Trial.
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group. Specks U, et al. N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277. N Engl J Med. 2013. PMID: 23902481 Free PMC article. Clinical Trial.
Inflammatory arthritis in systemic sclerosis: What to do?
Blank RB, Nwawka OK, Yusov AA, Gordon JK. Blank RB, et al. Among authors: gordon jk. J Scleroderma Relat Disord. 2019 Feb;4(1):3-16. doi: 10.1177/2397198318779532. Epub 2018 Jun 19. J Scleroderma Relat Disord. 2019. PMID: 35382152 Free PMC article. Review.
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.
Luo Y, Assassi S, Mayes MD, Frech TM, Steen VD, Richardson C, Chung L, Sandorfi N, VanBuren JM, Harding M, Alvey JS, Skaug B, McMahan ZH, Lakin KS, Zahn C, Bracken SJ, Lebiedz-Odrobina DJ, Molitor JA, Evnin LB, Moore DF, Shah A, Castelino FV, Volkmann ER, Hant FN, Makol A, Shah AA, Hummers LK, Gordon JK, Khanna D, Bernstein EJ. Luo Y, et al. Among authors: gordon jk. Ann Am Thorac Soc. 2025 Aug;22(8):1265-1269. doi: 10.1513/AnnalsATS.202410-1045RL. Ann Am Thorac Soc. 2025. PMID: 40208257 No abstract available.
126 results